A systematic study of yeast sterol biosynthetic protein-protein interactions using the split-ubiquitin system.

Department of Biology, Indiana University-Purdue University Indianapolis, 723 W. Michigan St. Indianapolis, IN 46202, USA.
Biochimica et Biophysica Acta (Impact Factor: 4.66). 01/2006; 1737(2-3):152-60. DOI: 10.1016/j.bbalip.2005.11.002
Source: PubMed

ABSTRACT Sterol biosynthesis occurs in the ER and most sterol biosynthetic enzymes have transmembrane domains. However, due to difficulties in characterizing membrane protein-protein interactions, the nature of the sterol biosynthetic complex as well as in vivo interactions between various enzymes have not been described. We employed a split-ubiquitin membrane protein yeast two-hybrid system to characterize interactions between sterol biosynthetic proteins. Fourteen bait constructs were co-transformed into a reporter yeast strain with 14 prey constructs representing all sterol enzymatic reactions beginning with the synthesis of squalene. Our results not only confirmed several previous interactions, but also allowed us to identify novel interactions. Based on these results, ergosterol biosynthetic enzymes display specific protein-protein interactions forming a functional complex we designate, the ergosome. In this complex, Erg11p, Erg25p, Erg27p, and Erg28p appear to form a core center that can interact with other enzymes in the pathway. Also Erg24p and Erg2p, two enzymes that are sensitive to morpholine antifungals, appear to interact with one another; however, the profile of protein interaction partners appears to be unique. Erg2p and Erg3p, two enzymes catalyzing sequential reactions also appear to have different interaction partners. Our results provide a working model as to how sterol biosynthetic enzymes are topologically organized not only in yeast but in plant and animal systems that share many of these biosynthetic reactions.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The assembly of cooperating enzymes into multicatalytic complexes, also known as “metabolons,” has become a well-accepted concept in cellular metabolism, at least in principle. There are still relatively few examples where the existence of such systems is supported by solid experimental evidence and even fewer where there is evidence for “channeling” of metabolites through the complex. However, proteomic approaches are providing new evidence for the pervasiveness of this type of organization, while structural biology is offering insights into how these systems are constructed and regulated. New and improved technologies for analyzing protein interactions and assemblies, both in vitro and in intact cells, are opening the doors to explo-ring the intracellular organization of a growing number of metabolic complexes in plants and other organisms. There is also an increasing appre-ciation of the surprising scale of many protein interaction networks, the multiple functions of individual proteins, and the importance (and challenges) of compartmentalization. As a result, the concept of enzyme complexes is gaining wider acceptance and becoming an increasingly important consideration in efforts to engineer metabolism.
    12/2008: pages 195-208;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Bitopic integral membrane proteins with a single transmembrane helix play diverse roles in catalysis, cell signaling, and morphogenesis. Complete monospanning protein structures are needed to show how interaction between the transmembrane helix and catalytic domain might influence association with the membrane and function. We report crystal structures of full-length Saccharomyces cerevisiae lanosterol 14α-demethylase, a membrane monospanning cytochrome P450 of the CYP51 family that catalyzes the first postcyclization step in ergosterol biosynthesis and is inhibited by triazole drugs. The structures reveal a well-ordered N-terminal amphipathic helix preceding a putative transmembrane helix that would constrain the catalytic domain orientation to lie partly in the lipid bilayer. The structures locate the substrate lanosterol, identify putative substrate and product channels, and reveal constrained interactions with triazole antifungal drugs that are important for drug design and understanding drug resistance.
    Proceedings of the National Academy of Sciences 02/2014; DOI:10.1073/pnas.1324245111 · 9.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In yeast, deletion of ERG27, which encodes the sterol biosynthetic enzyme, 3-keto-reductase, results in a concomitant loss of the upstream enzyme, Erg7p, an oxidosqualene cyclase (OSC). However, this phenomenon occurs only in fungi, as mammalian Erg27p orthologues are unable to rescue yeast Erg7p activity. In this study, an erg27 mutant containing the mouse ERG27 orthologue was isolated that was capable of growing without sterol supplementation (FGerg27). GC/MS analysis of this strain showed an accumulation of squalene epoxides, 3-ketosterones, and ergosterol. This strain which was crossed to a wildtype and daughter segregants showed an accumulation of squalene epoxides as well as ergosterol indicating that the mutation entailed a leaky block at ERG7. Upon sequencing the yeast ERG7 gene an A598S alteration was found in a conserved alpha helical region. We theorize that this mutation stabilizes Erg7p in a conformation that mimics Erg27p binding. This mutation, while decreasing OSC activity still retains sufficient residual OSC activity such that the strain can function in the presence of the mammalian 3-keto reductase enzyme and no longer requires the yeast Erg27p. Because sterol biosynthesis occurs in the ER, a fusion protein was synthesized combining Erg7p and Erg28p, a resident ER protein and scaffold of the C-4 demethyation complex. Both FGerg27 and erg27 strains containing this fusion plasmid and the mouse ERG27 orthologue showed restoration of ergosterol biosynthesis with minimal accumulation of squalene epoxides. These results indicate retention of Erg7p in the ER increases its activity and suggest a novel method of regulation of ergosterol biosynthesis.
    Biochimica et Biophysica Acta 09/2012; DOI:10.1016/j.bbalip.2012.09.012 · 4.66 Impact Factor